It’s also well known to be associated with a myriad of clinical presentations including Castleman’s disease, sclerotic bone lesions, pulmonary manifestations, clubbing, weight loss, thrombocytosis, polycythemia, extravascular volume overload and elevated VEGF levels [1]. Here, VEGFA is linked to thrombocytosis disease.